ISSN: 0012-6667

Journal Home

Journal Guideline

Drugs Q1 Unclaimed

Adis International Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drugs is a journal indexed in SJR in Pharmacology (medical) with an H index of 171. It has a price of 3790 €. It has an SJR impact factor of 2.081 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2.081.

Drugs focuses its scope in these topics and keywords: review, patients, therapeutic, combined, cellular, complications, concepts, current, development, developmentvonoprazan, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (medical) (Q1)

Price

3790 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2.081

SJR Impact factor

171

H Index

176

Total Docs (Last Year)

510

Total Docs (3 years)

10008

Total Refs

4946

Total Cites (3 years)

492

Citable Docs (3 years)

9.97

Cites/Doc (2 years)

56.86

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Perspectives in Medicinal Chemistry Q1
Drug Resistance Updates Q1
American Journal of Transplantation Q1
Pharmacology and Therapeutics Q1
Alimentary Pharmacology and Therapeutics Q1

Compare this journals

Aims and Scope

Best articles by citations

Correction to: Polatuzumab Vedotin: First Global Approval

The Incidence and Antibiotic Susceptibility of Branhamella catarrhalis in Respiratory Infections

Pharmacology and Clinical Experience with Tramadol in Osteoarthritis

Clinical Aspects of Invasive Candidiasis in Paediatric Patients

Current and Emerging Therapeutics for the Management of Endometriosis

Cidofovir

Enalapril

Rifaximin

Enalapril in Hypertension and Congestive Heart Failure

Quinolones in Sexually Transmitted Diseases

Correction to: Secukinumab: A Review in Ankylosing Spondylitis

Basiliximab

SHOW MORE ARTICLES

Quinupristin/Dalfopristin

Treatment of Epilepsy in Pregnancy

Managing Resistance to Anti-HIV Drugs

Otitis Media and Sinusitis in Children Role of Branhamella catarrhalis

Incidence of Branhamella catarrhalis in the Sputa of Patients with Chronic Lung Disease

Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications

Are All Dopamine Agonists Essentially the Same?

Emerging Resistance to Antimicrobial Agents in Gram-Positive Bacteria

Efficacy and Safety of New Oral Anticoagulants for Extended Treatment of Venous Thromboembolism: Systematic Review and Meta-Analyses of Randomized Controlled Trials

How Does Tinidazole Compare with Metronidazole?

Importance of Drug Enantiomers in Clinical Pharmacology

Gemifloxacin